Ligand Pharmaceuticals
LGND
LGND
192 hedge funds and large institutions have $1.3B invested in Ligand Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8% less capital invested
Capital invested by funds: $1.4B → $1.3B (-$106M)
40% less call options, than puts
Call options by funds: $8.25M | Put options by funds: $13.8M
Holders
192
Holding in Top 10
6
Calls
$8.25M
Puts
$13.8M
Top Buyers
| 1 | +$15.2M | |
| 2 | +$10.6M | |
| 3 | +$9.37M | |
| 4 |
NAM
Nichols Asset Management
Sudbury,
Massachusetts
|
+$8.12M |
| 5 |
Goldman Sachs
New York
|
+$4.64M |
Top Sellers
| 1 | -$15M | |
| 2 | -$12.7M | |
| 3 | -$9.6M | |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$8.43M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$7.34M |